Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 1.161
2.
J Dermatolog Treat ; 35(1): 2313090, 2024 Dec.
Article En | MEDLINE | ID: mdl-38317538

Aim: To evaluate the therapeutic efficacy and safety of JAK inhibitor abrocitinib in patients with localized granuloma annulare (GA) and to review the available cases documented in English.Methods: We presented a patient who had a persistent, localized granuloma anulare (GA) for one year and did not respond to traditional therapies. This patient was treated with oral abrocitinib at a dosage of 150 mg daily.Results: After 6 weeks of treatment with abrocitinib, the patient exhibited notable symptom improvement with no new lesions. No adverse events or recurrences were reported during the 5-month follow-up period.Conclusions: Abrocitinib may be a promising and safe treatment option for patients with localized GA who do not respond to traditional therapies.


Granuloma Annulare , Janus Kinase Inhibitors , Humans , Granuloma Annulare/drug therapy , Granuloma Annulare/pathology , Pyrimidines/therapeutic use , Sulfonamides/therapeutic use , Janus Kinase Inhibitors/therapeutic use , Treatment Outcome
9.
Int J Dermatol ; 63(5): 655-659, 2024 May.
Article En | MEDLINE | ID: mdl-38135676

BACKGROUND: Type 1 (Th1) and Type 2 (Th2) immunity have both been implicated in granuloma annulare (GA). To what extent these pathways contribute to clinical/histologic heterogeneity and/or distinct disease endotypes remains unexplored. METHODS: We retrospectively analyzed 30 GA biopsies with either palisaded or interstitial histology with and without eosinophils. We performed RNA in situ hybridization to assess how markers of Type 1 (interferon gamma), Type 2 (interleukin [IL]4, IL13, IL5), and Type 3 (IL17A) immunity in GA compared with canonical inflammatory disorders and whether markers correlated with histology. We analyzed another cohort of 14 patients who had multiple biopsies across anatomic space and time for individual conservation of histologic features. RESULTS: Interferon (IFN)G staining is highest in GA relative to other cytokines. Type 2 cytokine staining is less prominent, with IL4 increased in interstitial pattern cases. Eosinophils did not correlate with Type 2 markers. Patients with multiple biopsies display intrapatient variability in histology. CONCLUSION: Type 1 inflammation predominates over Type 2 inflammation in GA irrespective of histologic pattern. Distinct disease endotypes were not detected.


Eosinophils , Granuloma Annulare , Humans , Retrospective Studies , Granuloma Annulare/pathology , Granuloma Annulare/immunology , Granuloma Annulare/diagnosis , Male , Female , Eosinophils/pathology , Eosinophils/immunology , Middle Aged , Biopsy , Adult , Interferon-gamma , Interleukin-4 , Th2 Cells/immunology , Interleukin-17/metabolism , Interleukin-5 , Th1 Cells/immunology , Aged , Staining and Labeling , Cytokines/metabolism , Skin/pathology , Skin/immunology , Young Adult , In Situ Hybridization
12.
Int J Mol Sci ; 24(17)2023 Aug 28.
Article En | MEDLINE | ID: mdl-37686161

This investigation demonstrates the use of dimethyl fumarate (DMF) for the treatment of disseminated granuloma annulare (GAD), a rare and chronic inflammatory skin disease. In this case, progressive GAD was treated with DMF, resulting in significant improvement of skin lesions within 5 weeks and complete healing within 7 months. Clinical response was associated with a reduction in inflammatory cells, including both T cell subsets (CD4+ > CD8+), CD183+/CXCR3+ cells, Langerhans cells (CD1a+), myeloid DCs, M1- and M2-like macrophages and the activation marker HLA-DR in immunohistochemical analysis. These findings support the use of DMF as a promising treatment option for this rare skin condition.


Dermatitis , Granuloma Annulare , Humans , Granuloma Annulare/drug therapy , Dimethyl Fumarate/therapeutic use , Treatment Outcome , Skin , Rare Diseases
13.
Am J Dermatopathol ; 45(9): 654-657, 2023 Sep 01.
Article En | MEDLINE | ID: mdl-37625804

ABSTRACT: Giant cell arteritis (GCA) is a diagnosis that clinicians should not miss because of the accompanying risk of irreversible vision loss. GCA can present without the classic symptoms of headache and temporal artery tenderness, which may lead to a delay in diagnosis. Cutaneous findings, although rare, have been associated with GCA. Accordingly, it is imperative to be aware of the broad clinical and histological presentations of GCA, including the cutaneous findings, because they may prove to be harbingers of impending disease. We present a unique case of GCA where 2 distinct cutaneous morphologies, sarcoidal granuloma annulare-like dermatitis and leukocytoclastic vasculitis with granulomatous features, presented simultaneously before the classic symptoms of headache and unilateral vision loss.


Dermatitis , Giant Cell Arteritis , Granuloma Annulare , Vasculitis, Leukocytoclastic, Cutaneous , Humans , Giant Cell Arteritis/complications , Giant Cell Arteritis/diagnosis , Granuloma Annulare/diagnosis , Vasculitis, Leukocytoclastic, Cutaneous/diagnosis , Vasculitis, Leukocytoclastic, Cutaneous/drug therapy , Vasculitis, Leukocytoclastic, Cutaneous/etiology , Headache
15.
J Ultrasound ; 26(4): 845-850, 2023 Dec.
Article En | MEDLINE | ID: mdl-37523040

BACKGROUND: Granuloma annulare (GA) is a rare, benign, inflammatory, self-limited, granulomatous dermatosis that affects children and young adults. The most frequent clinical form is localized GA. Deep GA generally presents as painless palpable subcutaneous nodules in the lower extremities, buttocks, hands and scalp. They may have a fast-growing firm subcutaneous mass presentation, mimicking a malignant lesion which requires an imaging evaluation. Diagnosis of deep GA can be more difficult and imaging evaluation is frequently performed, ultrasound being one of the techniques used. OBJECTIVE: To describe the US characteristics of GA in a pediatric series. MATERIALS AND METHOD: Descriptive, retrospective, 14-year study of all pediatrics GA cases. RESULTS: Twelve pediatric cases with GA. 66% females. The lesions were mainly distributed in the extremities: 50% in the lower extremities and 42% in the upper extremities, mostly with multiple lesions. A total of 45 lesions were analyzed, 8 superficial lesions and 37 deep lesions. On ultrasound, the superficial GA corresponded to hypoechoic poorly defined solid plaque like or nodular lesions, located in the dermal-epidermal plane. The deep GA presented as solid nodular, poorly defined hypoechoic lesions that compromised the deep subcutaneous-aponeurotic plane. CONCLUSION: GA is an inflammatory lesion that presents as a superficial or deep palpable nodule that predominantly affects children. Superficial and deep GA present characteristic findings on US that can guide the diagnosis. The radiologist needs to know its US appearance to be able to suggest the diagnosis, especially in multiples lesions.


Granuloma Annulare , Female , Humans , Child , Male , Granuloma Annulare/diagnostic imaging , Granuloma Annulare/pathology , Retrospective Studies , Ultrasonography , Scalp/pathology , Diagnosis, Differential
18.
J Med Case Rep ; 17(1): 192, 2023 May 11.
Article En | MEDLINE | ID: mdl-37165446

BACKGROUND: Dermatologic signs and symptoms can be the manifestations of a single disease or different diseases, and it is proven that some are associated with one another. These connections are not fully understood, but the answer lies in the pathophysiology of each disease. CASE PRESENTATION: We report the case of a 6-year-old Middle-Eastern girl who presented with two skin lesions on the dorsum of her foot, along with scaling of her soles and palms, face skin discoloration, and areas of patchy alopecia on her scalp. She was diagnosed as a case of acute onset of granuloma annulare with alopecia areata and dermatitis. The treatment regimen for the patient's scalp consisted of topical minoxidil and betamethasone and three sessions with 1-month intervals of triamcinolone acetonide intralesional injections, which demonstrated modest effectiveness in treating alopecia areata. CONCLUSION: Granuloma annulare is a benign inflammatory illness with no known cause that might be difficult to cure. The clinical course and prognosis might vary greatly depending on the disease subtype, and associating symptoms and diseases, such as alopecia areata, should be considered.


Alopecia Areata , Granuloma Annulare , Female , Humans , Child , Alopecia Areata/complications , Alopecia Areata/drug therapy , Granuloma Annulare/complications , Granuloma Annulare/drug therapy , Granuloma Annulare/pathology , Glucocorticoids/therapeutic use , Scalp/pathology
19.
Dermatologie (Heidelb) ; 74(4): 243-249, 2023 Apr.
Article De | MEDLINE | ID: mdl-36881125

Dermoscopy is an easily accessible, noninvasive diagnostic tool, originally used in the differentiation of benign and malignant skin tumors. Other structures beside pigment content observed by dermoscopy, e.g., scaling, follicles, or vessels, may present in a specific pattern in different dermatoses. Recognition of these patterns may aid the diagnosis of inflammatory and infectious dermatological conditions. The aim of this article is to review the distinct dermoscopic features of granulomatous and autoimmune skin diseases. Diagnosis of granulomatous skin disorders is based on the histopathological examination. The dermoscopic picture of these diseases (cutaneous sarcoidosis, granuloma annulare, necrobiosis lipoidica, and granulomatous rosacea) show many similarities; however, there are some differences to note between the dermatoses, mainly in granuloma annulare. The cornerstones of the diagnostic process of autoimmune skin diseases (morphea, systemic sclerosis, dermatomyositis, cutaneous lupus erythematosus) include the clinical picture, immunoserology, and histology; however, dermoscopy may aid the diagnostic process and follow-up of the patients. For those diseases, where vascular abnormalities play an important role in the pathogenesis, videocapillaroscopy is used for examination of the microcirculation at the nailfold capillaries. Dermoscopy can be an easy-to-use everyday diagnostic tool in clinical practice regarding granulomatous and autoimmune skin diseases. Although punch biopsy is inevitable in many cases, the distinct dermoscopic structures can aid the diagnostic process.


Autoimmune Diseases , Granuloma Annulare , Lupus Erythematosus, Cutaneous , Sarcoidosis , Humans , Granuloma Annulare/diagnosis , Dermoscopy , Skin/pathology , Sarcoidosis/diagnosis , Autoimmune Diseases/diagnosis
...